CEO LEADERSHIP SERIES

ASHTON TWEED'S CEO INTERVIEWS

May 31, 2016

CEO Leadership Series: Kenneth L. Londoner, Executive Chairman, BioSig Technologies, Inc.

AN ENTREPRENEURIAL PATHWAY TO LEADERSHIP With an investment and business development background, Kenneth L. Londoner’s career is proof no set or predictable path to running a […]
April 14, 2016
Francois R. Martelet, Chief Executive Officer, NetScientific Plc

CEO Leadership Series: Francois R. Martelet, Chief Executive Officer, NetScientific Plc

TAKING THE REINS OF A HEALTHCARE TECHNOLOGY INVESTMENT COMPANY French by birth, based in London and doing business in the San Francisco Bay-area biotech community, Dr. […]
March 17, 2016
Ivan R. Sabel, Chief Executive Officer, Orthotic Holdings Inc.

CEO Leadership Series: Ivan R. Sabel, Chief Executive Officer, Orthotic Holdings Inc.

PASSION FOR PATIENT CARE HELPS BUILD BUSINESS As the CEO of Orthotic Holdings Inc. (OHI), Ivan R. Sabel draws on his experience as both a practitioner […]
January 29, 2016
Kathleen P. DeLawrence, Chief Operating Officer, Ability Prosthetics & Orthotics, Inc.

CEO Leadership Series: Kathleen P. DeLawrence, Chief Operating Officer, Ability Prosthetics & Orthotics, Inc.

MAKING CONNECTIONS AND SEIZING OPPORTUNITIES Kathleen P. DeLawrence, Chief Operating Officer of Ability Prosthetics & Orthotics, Inc., has an impressive breadth of experience in the pharmaceutical, […]
December 9, 2015
Graham G. Lumsden, CEO, Motif Bio plc

CEO Leadership Series: Graham G. Lumsden, CEO, Motif Bio plc

AFTER DECADES AT MERCK, A NEW ENTREPRENEURIAL BEGINNING After 26 years at Merck & Co. Inc., Graham G. Lumsden was evaluating his career options. He decided […]
October 28, 2015
Renold J. Capocasale, Founder and CEO, FlowMetric Inc.

CEO Leadership Series: Renold J. Capocasale, Founder and CEO, FlowMetric Inc.

FROM BIG PHARMA LAYOFF TO LAUNCHING A CRO When Renold J. Capocasale learned that he was being laid off by Johnson & Johnson, where he had […]
September 21, 2015
Michael J. Daley, PhD, President and CEO, OrthogenRX, Inc.

CEO Leadership Series: Michael J. Daley, PhD, President and CEO, OrthogenRX, Inc.

FROM SEED FUNDING TO FDA APPROVAL IN 20 MONTHS! The biopharmaceutical industry was abuzz earlier this month with the long-awaited launch of Sandoz’ Zarxio™ (filgrastim-sndz), the […]
August 12, 2015
Frank K. Bedu-Addo, PhD, President & CEO, PDS Biotechnology Corp.

CEO Leadership Series: Frank K. Bedu-Addo, PhD, President & CEO, PDS Biotechnology Corp.

TRANSITIONING FROM SCIENTIST TO CEO By the time he co-founded PDS Biotechnology Corp., a clinical-stage biotech company in North Brunswick, N.J., Dr. Frank K. Bedu-Addo had […]
June 28, 2015
J. David Owens, CEO, BiologicsMD, Inc.

CEO Leadership Series: J. David Owens, CEO, BiologicsMD, Inc.

HOW TO REINVENT YOURSELF IN TURBULENT TIMES David Owens is an expert on reinvention and the unconventional path to the C-suite. In 2009, after 30 years in […]
May 15, 2015
Dr. Warren Cooper, President, Coalescence Inc.

CEO Leadership Series: Dr. Warren Cooper, President, Coalescence Inc.

THE IMPORTANCE OF BUILDING A STRONG BOARD OF DIRECTORS The composition of a company’s board of directors ultimately can make or break a business. Warren Cooper, […]
September 4, 2014
James E. Sapirstein, RPh., M.B.A.,CEO and director of ContraVir Pharmaceuticals, Inc.

CEO Leadership Series: James E. Sapirstein, CEO & Director, ContraVir Pharmaceuticals, Inc.

PRIVATE VS. PUBLIC COMPANY LEADERSHIP “To be successful as a chief executive officer, you have to know how to run an enterprise. You have to be […]
April 17, 2014
David Johnson, CEO of Alliqua, Inc.

CEO Leadership Series: David Johnson, CEO, Alliqua, Inc.

MAKING A SMOOTH TRANSITION FROM A LARGE MEDICAL DEVICE FIRM TO A SMALL BIOPHARMACEUTICAL COMPANY Last year, David Johnson made a big change in his career […]
March 1, 2013

CEO Leadership Series: Baruch Ben Dor, PhD, President & CEO, InfraScan Inc.

A ROLLER-COASTER RIDE TO SUCCESS IN THE MEDICAL DEVICE INDUSTRY When someone gets a serious head injury, the prompt detection of intracranial bleeding can be a […]
September 1, 2012

CEO Leadership Series: Donna L. Tempel, PhD, President and CEO, Drais Pharmaceuticals, Inc.

USING VIRTUAL BIOTECHS TO MOVE DRUGS INTO DEVELOPMENT MORE EFFICIENTLY This year, Bridgewater, NJ-based Drais Pharmaceuticals, Inc., has launched a new business model. According to Drais […]
June 1, 2012

CEO Leadership Series: Dr. Warren Cooper, Former President & CEO, Prism Pharmaceuticals

SUCCESS STRATEGIES FOR NEW DRUG DEVELOPMENT TODAY Originally published in Ashton Tweed Connection, Summer 2012 As the former President and CEO of Prism Pharmaceuticals, Dr. Warren […]
portrait of a businessman and a businesswoman leader

ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?

CONTACT US TO DISCUSS AN INTERVIEW:

Jordan Warshafsky
Partner, Ashton Tweed Ltd.
Email: JWarshafsky@ashtontweed.com
Phone: 610.725.0290 x441

Ashton Tweed, Ltd.
565 E. Swedesford Rd.
Suite 214
Wayne, PA 19087